BURLINGTON, N.C., Jan. 8, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on March 12, 2025, to stockholders of record as of the close of business on February 27, 2025.About LabcorpLabcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospita ...

BURLINGTON, N.C., Jan. 8, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the fourth quarter of 2024 before the market opens on Thursday, February 6, 2025. The company will host a conference call and webcast beginning at 9 a.m. ET that day to discuss the results. The earnings press release and accompanying financial information will be posted on the Labcorp Investor Relations website.The call w ...

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers.Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Value ...

Labcorp Holdings Inc. (LH) , or Labcorp, is targeting high-growth areas as part of its expansion. By partnering with health systems and regional local laboratories, the company is leveraging science and innovation to lead in important therapeutic areas. Moreover, the LaunchPad initiative is contributing to strong margin performance. Yet, the adverse macroeconomic impacts and currency fluctuations may dent its growth.In the past year, this Zacks Rank #3 (Hold) stock has risen 1.3% compared with the 1.2% grow ...

Labcorp Holdings, Inc. (LH) recently entered into a comprehensive strategic agreement with Graves Gilbert Clinic, the largest physician-owned medical group in South-Central Kentucky. The partnership will support their efforts to reduce costs, improve access and reinforce their position as the high-value care provider in the region.The latest development follows other strategic collaborations that Labcorp has established with a range of local and regional health systems, enhancing services for patients and p ...

Labcorp (LH) recently announced the commercial availability of its new H5 bird flu molecular test in the United States. The test will help physicians diagnose patients suspected of infection with the H5N1 virus.The test was developed in collaboration with the CDC (Centers for Disease Control and Prevention) to support public health preparedness strategies.LH Stock’s Likely Trend Following the NewsSince the announcement on Dec. 17, Labcorp shares have fallen 2%, finishing at $226.31 yesterday. On a promising ...

Labcorp Holdings, Inc. (LH) has entered into an agreement with MAWD Pathology Group in Lenexa, KS, to acquire select assets of its clinical and women’s health testing businesses. Both companies share a commitment to improving community health through high-quality laboratory services.The transaction is anticipated to close in early 2025, subject to customary closing conditions.  In the meantime, operations or services will remain unchanged.LH Stock’s Likely Trend Following the NewsFollowing the announcement ...

New test supports public health preparedness efforts and testing infrastructure amid multistate outbreak of H5 bird flu in poultry and dairy cows BURLINGTON, N.C., Dec. 17, 2024 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the commercial availability of its new H5 bird flu molecular test to aid in the diagnosis of human infection with H5 bird flu. The test is available in the United States to physicians to order for patients suspect ...

The Future Investor with Albert Anthony is a new series of curated research articles on the Seeking Alpha platform, focusing on growing a diversified portfolio and unlocking future drivers of performance.Albert Anthony is the pen name of a contributing analyst who has covered over +200 stocks on this platform since 2023, growing to over 1.07K followers. Based on this new article series, he is also working on a new book on Amazon to be called The Future Investor: Growing a Diversified Portfolio (2025 edition ...

Research to be presented in a joint poster session with Labcorp at the 2024 San Antonio Breast Cancer SymposiumBOSTON and BURLINGTON, N.C., Nov. 26, 2024 /PRNewswire/ -- Outcomes4Me Inc., the developer of the first and only end-to-end, actionable cancer platform, announced today it has been selected to present the results of a biomarker awareness study, conducted with Labcorp, a global leader of innovative and comprehensive laboratory services, at the prestigious 2024 San Antonio Breast Cancer Symposium (SA ...